Nursing Homes on Constipation and General Comfort

NCT ID: NCT06788392

Last Updated: 2025-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Effect of Reminiscence Therapy on Constipation Applied to Elderly Individuals Staying in a Nursing Home in Giresun Province

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Research; This study will be conducted to determine the effect of reminiscence therapy, given once or twice a week to elderly people living in nursing homes, on constipation by reducing stress levels. It is thought that the results obtained will provide evidence for reducing constipation, which significantly limits life. Patients who complain of constipation at the Nursing Home Elderly Care and Rehabilitation Center, who voluntarily agree to participate in the research and who meet the sample selection criteria will be included in the study. Patient information will be collected and the research pre-test, post-test and application will be carried out face to face.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Constipation Nursing Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Block randomisation will be used to ensure that the number of patients in each group is balanced. Patients will be divided into two groups, each group consisting of at least 38 people, by a statistician who is not involved in the study, using a table of random numbers.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors
In the study, blinding will be performed only in the assignment-randomisation to groups and statistical analysis of the results.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

interventional

Group receiving reminiscence therapy 2 days a week

Group Type EXPERIMENTAL

reminiscence therapy

Intervention Type OTHER

Reminiscence Therapy is a supportive care model that has been used in recent years and increases life comfort.

control

The group in which no intervention and receiving routine nursing care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

reminiscence therapy

Reminiscence Therapy is a supportive care model that has been used in recent years and increases life comfort.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those aged 65 and over,
* Able to answer all questions and be communicative,
* Scoring 24 or above from the Mini Mental test,
* Agreeing to participate in the research,
* Diagnosed with constipation by the institution physician and meeting the Rome III Constipation Diagnostic Criteria,
* There is no deterioration in skin integrity or infection in the abdominal area,
* No diarrhea,
* Individuals without a history of abdominal surgery will be included in the study.

Exclusion Criteria

* Psychiatric drug users,
* Those who score below 24 on the Mini Mental Test,
* Those who do not meet the Rome III Diagnostic Criteria for Constipation,
* Those with impaired skin integrity or infection in the abdominal area,
* People with diarrhoea,
* History of abdominal surgery Those who refused to participate in the study
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kafkas University

OTHER

Sponsor Role collaborator

Giresun Huzurevi Yaşlı Bakım ve Rehabilitasyon Merkezi

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

KEVSER KASAP

Nurse

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Giresun Huzurevi Yaşli Bakim Ve Rehabilitasyon Merkezi

Giresun, Merkez, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Kevser KASAP

Identifier Type: OTHER

Identifier Source: secondary_id

AIBU-SBF-KK-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Traveler's Constipation
NCT06155929 COMPLETED NA